{"retracted":false,"update":{"timestamp":1383264000000,"doi":"10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116","type":"correction"},"doi":"10.1371/journal.pone.0076462","journal":"PLoS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis"}
